GFAP and Parkinson disease: In light of the finding that in Parkinson’s disease model mice astrocytic endfeet, which typically express little or no GFAP, rather than the cell bodies, where GFAP is more abundant [30, 86], showed a close proximity to the BBB leakages, we examined whether RBC-EVs might be taken up by the distal processes of astrocytes.